Endoscopic Evaluation of Biliary Strictures: Current and Emerging Techniques
Article information
Abstract
The diagnosis of biliary strictures in clinical practice can be challenging. Discriminating between benign and malignant biliary strictures is important to prevent the morbidity and mortality associated with incorrect diagnoses. Missing a malignant biliary stricture may delay surgery, resulting in poor prognostic outcomes. Conversely, it has been demonstrated that approximately 20% of patients who undergo surgery for suspected biliary malignancies have a benign etiology on histopathology. Traditional tissue sampling using endoscopic retrograde cholangiography does not always produce a definitive diagnosis, with a considerable proportion of cases remaining as indeterminate biliary strictures. Recent advances in endoscopic techniques have the potential to improve the diagnostic and prognostic accuracy of biliary strictures.
INTRODUCTION
Biliary strictures can be broadly classified into benign or malignant causes. Differentiating between the two etiologies allows timely management of malignant strictures and avoids unnecessary surgery for benign strictures [1]. A common precept among surgeons is to assume that all biliary strictures are malignant until proven otherwise [2–4]. This safeguards against missing a diagnosis of malignancy but has contributed to a considerable number of patients with benign biliary strictures undergoing surgery [5–7]. Unfortunately, the diagnostic workup for biliary strictures is modest at best, resulting in a proportion of cases where the etiology remains unknown [8]. These biliary strictures are termed “indeterminate strictures” and pose a therapeutic dilemma to clinicians involved in their management [9].
The etiology of benign biliary strictures is diverse. Iatrogenic injury to the bile duct after cholecystectomy or liver transplantation is the most common overall cause of biliary strictures [10]. Autoinflammatory causes include primary sclerosing cholangitis (PSC) [11], immunoglobulin G4 (IgG4)-associated cholangitis [12], and sarcoidosis [13]. Impaction of gallstones in the cystic duct or Hartmann’s pouch can result in extrinsic ductal compression [14]. Infective causes, such as acquired immunodeficiency syndrome cholangiopathy, are associated with multiple pathogens [15], the most common being Cryptosporidium parvum [16], although some cases may have no identifiable pathogens.
With respect to malignant biliary strictures, the two primary causes are cholangiocarcinoma and pancreatic adenocarcinoma [17,18]. Malignant strictures of the proximal to middle bile duct portions are more likely to be cholangiocarcinoma than pancreatic adenocarcinoma, which tends to cause distal bile duct strictures [19]. Rarer causes of malignant biliary strictures include metastatic disease [20], lymphoproliferative disease [21], gallbladder carcinoma [22], and hepatocellular carcinoma [23].
The current approaches to the evaluation of biliary strictures seem to have high specificity but lack sensitivity, leading to diagnostic uncertainty [9,10]. The fear of missing a potential malignancy has prompted many surgeons to operate in cases in which the diagnosis remains uncertain. Up to 20% of suspected biliary malignancies are revealed to be benign after surgical resection [5,6,24]. Surgery is associated with appreciable morbidity and mortality rates. Hence, there is a need to develop techniques that will improve the diagnosis of biliary strictures. This article will review current and recently developed endoscopic approaches for the evaluation of biliary strictures. Conventional methods such as endoscopic retrograde cholangiopancreatography, endoscopic ultrasound, intraductal ultrasound, and cholangioscopy will be discussed along with emerging techniques such as confocal laser endomicroscopy, fluorescence in situ hybridization, and optical coherence tomography.
CURRENT ENDOSCOPIC TECHNIQUES
Endoscopic retrograde cholangiopancreatography
Endoscopic retrograde cholangiopancreatography (ERCP) remains the most widely used diagnostic approach for the evaluation of biliary strictures. Initial evaluation by ERCP allows the precise definition of the location, extent, and morphology of biliary strictures (Fig. 1) [25,26]. Malignant strictures are usually characterized as being long and irregular with evidence of shouldering [27,28]. Unfortunately, the morphology of strictures is not useful in providing a specific diagnosis, and tissue sampling using either brush cytology or intraductal biopsies is required [29]. Brush cytology is more commonly performed because it is easier and associated with fewer complications [30,31]. Conversely, intraductal biopsies provide greater microarchitecture detail, but require sphincterotomy and can be challenging in narrow bile ducts [32]. The diagnostic advantage of intraductal biopsies over cytology brushings has also not been demonstrated. A meta-analysis performed by Navaneethan et al. [33] showed that the pooled sensitivity and specificity of brush cytology in the diagnosis of malignant strictures were 45% (95% confidence interval [CI], 40–50%) and 99% (95% CI, 98–100%), respectively. For intraductal biopsies, the pooled sensitivity and specificity were comparable at 48.1% (95% CI, 42.8–53.4%) and 99.2% (95% CI, 97.6–99.8%), respectively. Combining the two modalities increased the sensitivity marginally to 59.4% (95% CI, 53.7–64.8%), with a specificity of 100%.
The poor sensitivity of tissue sampling through ERCP has been attributed to multiple factors, including the effects of desmoplasia in malignancy, which can reduce the yield of samples obtained with brush cytology [34,35]. Furthermore, inflammation secondary to obstruction or infection can cause cellular changes such as hyperplasia or degenerative disfigurements, making it difficult to distinguish between benign and malignant lesions [36]. Although the diagnostic yield of tissue sampling is reliant on the morphology of the stricture, other factors including the technical skill of the endoscopist and the interpretative ability of the pathologist remain important factors [37,38]. Increasing the number of brushings has been shown to improve diagnostic accuracy; however, stricture dilation or increasing the brush length does not [39,40].
Endoscopic ultrasound
Endoscopic ultrasound (EUS) can differentiate between benign and malignant strictures by allowing sonographic visualization of the biliary tract along with the surrounding viscera including the pancreas (Fig. 2) [41]. An echoendoscope, which comprises a transducer probe incorporated into the tip of an endoscope, is advanced into the duodenum. The transducer probe can be either radial or linear. Radial probes permit a full rotational view of the anatomy, whereas linear probes are more suitable for interventional procedures such as fine-needle aspiration (FNA) [42]. Assessment of the common bile duct is usually performed from the duodenal bulb, where the close proximity of the bile duct and transducer probe allows the biliary tract to be imaged along with surrounding structures such as the superior mesenteric vessels and para-aortic nodes [43].
Tissue sampling through EUS-guided FNA was first performed by Fritscher-Ravens et al. [44] in 10 patients with indeterminate biliary strictures. Further studies on EUS-guided FNA demonstrated improved accuracy when used in conjunction with ERCP and brush cytology. A recent meta-analysis by Sadeghi et al. [45] established the pooled sensitivity and specificity of EUS-guided FNA in the diagnosis of malignant biliary strictures to be 80% (95% CI, 74–86%) and 97% (95% CI, 94–99%), respectively. When the location of the biliary stricture was taken into consideration, EUS-guided FNA of distal strictures had a higher sensitivity (83% [95% CI, 68–98%]) than that of proximal strictures (76% [95% CI, 66–85%]); however, there was no difference in specificity. The practical efficacy of EUS-guided FNA depends on the site, size, and characteristics of the target lesion [46]. This has prompted the development of EUS-guided fine-needle biopsy (FNB), which uses a larger needle to obtain core biopsies from the suspected lesion. EUS-guided FNB enables obtaining tissue with better integrity and microarchitecture, allowing for innovative biomarker evaluation [47]. A recent randomized cross-over trial demonstrated that EUS-guided FNB had considerably higher diagnostic yield and specimen adequacy than FNA [48]. The use of EUS-guided FNA and FNB for preoperative diagnosis is currently debatable, with conflicting perspectives published by different governing bodies [49,50]. Given the lack of consolidated evidence, endoscopists should always consider the risk of malignant seeding when performing EUS-guided FNA or FNB, and make their decision on a case-by-case basis.
Intraductal ultrasound
Intraductal ultrasound (IDUS) has been shown to be more accurate than tissue sampling through ERCP in differentiating between benign and malignant biliary strictures [51–53]. This technique makes use of a thin ultrasound probe that can be inserted into the biliary tract without sphincterotomy [54]. Mechanical rotation of the probe permits a cross-sectional view of the bile duct. Features suggestive of malignancy include the presence of a sessile tumor, an interrupted wall structure, and a tumor size >10 mm. Tamada et al. [55] demonstrated that if IDUS showed at least two of these features, a malignancy should be considered even if the histologic findings are negative. The diagnostic utility of IDUS was assessed by Heinzow et al. [56] in 234 patients with indeterminate biliary strictures. IDUS was diagnostically superior to endoscopic transpapillary biopsies, EUS, and computed tomography in detecting malignant biliary strictures. The sensitivity and specificity of IDUS in this study were determined to be 93% (95% CI, 88–97%) and 89% (95% CI, 83–95%), respectively.
A major limitation of earlier IDUS was the inability to obtain biopsies for pathologic diagnosis. More recently, transpapillary biopsies have been performed under IDUS guidance. Kim et al. [57] performed a prospective comparative study that showed that IDUS-guided transpapillary biopsy has a higher diagnostic accuracy than fluoroscopic-guided transpapillary biopsy for the diagnosis of malignant biliary strictures (90.8% vs. 76.9%, p=0.027). The role of EUS can extend beyond the diagnosis and toward the staging of malignant strictures. IDUS has been shown to be more accurate than EUS in the T-staging of tumors [58,59]. However, the high frequencies used in IDUS preclude accurate nodal staging owing to poor tissue penetration [60]. IDUS may play a role in evaluating indeterminate biliary strictures; however, it is currently limited by the lack of technical expertise required to perform this procedure. Furthermore, previously placed stents can produce acoustic interference, reducing the diagnostic yield of IDUS [61].
Cholangioscopy
Direct visualization of the bile duct can be achieved using per-oral cholangioscopy. This technique initially lost popularity owing to its requirement for two endoscopists to operate the mother–baby endoscope. Additionally, the procedure was limited by poor maneuverability, small instrument channels, and inadequate tip deflection [62]. The development of single-operator cholangioscopy has recently led to a resurgence of interest in the use of this technique. Cholangioscopic inspection of the epithelium may provide macroscopic clues pertaining to malignancy. Any intraductal masses, nodules, or ulcerations should prompt direct biopsies from the region [16]. The presence of a “tumor vessel,” an irregular, dilated, and tortuous vessel, is considered a reliable feature of biliary malignancy [63,64]. A meta-analysis performed by Sun et al. [65] demonstrated that visual inspection alone using cholangioscopy is useful for detecting biliary malignancy, with pooled sensitivity and specificity of 90% (95% CI, 73–97%) and 87% (95% CI, 76–94%), respectively. However, confirmation using cholangioscopic-directed biopsies is still needed, which has an overall sensitivity and specificity of 69% (95% CI, 57–79%) and 98% (95% CI, 92–99%), respectively. Despite its diagnostic utility, the uptake of cholangioscopy has been relatively limited in many endoscopy centers. Many endoscopists perceive the procedure to be technically difficult, as it requires mastery in ERCP while concurrently operating the cholangioscope through the working channel. Nonetheless, studies have demonstrated a relatively quick learning curve with reportedly only 10 procedures needed to gain proficiency [66,67]. Cholangioscopy has been assessed by many studies to be a safe procedure even in elderly and comorbid patients [68,69]. Further research and development in cholangioscopy may increase the uptake of this technique in the future.
EMERGING ENDOSCOPIC TECHNIQUES
Confocal laser endomicroscopy
Confocal laser endomicroscopy (CLE) is a promising technique that can provide real-time, in vivo histologic imaging of the bile duct during ERCP [70–72]. The principle of CLE is based on the reflection of focused light through a confocal aperture to provide high-resolution histologic images (Fig. 3). This technique is performed using a catheter probe that is inserted through the working channel of an endoscope (probe-based CLE) or FNA equipment (needle-based CLE) [73]. The probe is advanced into the biliary system and the patient is injected with a contrast agent such as fluorescein, which extravasates into the biliary vasculature, highlighting the epithelial and subepithelial structures [72–74]. The diagnosis of a malignancy using CLE is based on the Miami classification criteria [74]. The malignant features according to these criteria include thick dark bands >40 µm, thick white bands >20 µm, epithelial structures, and dark clumps. CLE and the Miami classification have demonstrated better sensitivity but poorer specificity than traditional histology in the evaluation of biliary strictures. The low specificity has been attributed to changes induced by chronic inflammation or procedures performed during ERCP, such as cytology brushing [75]. To address this issue, the Paris classification was developed by Caillol et al. [76] to differentiate between benign inflammatory strictures and malignant strictures. The presence of vascular congestion, increased interglandular space, thickened reticular structures, and a granular pattern with scales are all features indicative of inflammatory biliary strictures.
Results from early studies exploring the use of CLE in the diagnosis of biliary strictures suggested an optimistic future. In a recent meta-analysis analyzing 12 studies involving 591 patients, Gao et al. [77] determined that the pooled sensitivity and specificity of CLE in discriminating between benign and malignant biliary strictures were 87% (95% CI, 83–91%) and 76% (95% CI, 70–81%), respectively. When used in combination with tissue sampling, the sensitivity and specificity increased to 93% (95% CI, 88–96%) and 82% (95% CI, 74–89%), respectively. However, the uptake of CLE has been slow. This may be because the procedure is technically difficult, as it requires probe stability to ensure high-quality images. Furthermore, the interobserver agreement between experienced endoscopists is poor, raising doubts about its diagnostic reliability [78]. However, these shortcomings can be overcome with standardized training [79]. Currently, CLE is practiced at only a few specialized centers and requires further validation to consolidate its place in clinical practice.
Fluorescence in situ hybridization
Fluorescence in situ hybridization (FISH) has been used for the detection of other malignancies, such as urothelial carcinoma, before its application in the evaluation of biliary strictures [80]. This technique makes use of fluorescently labeled DNA probes to detect aneuploidy associated with malignant biliary strictures. More specifically, polysomy of chromosomes 3, 7, and 17 centromeric regions or of the 1q21, 7p12, or 8q24 chromosomal region has been considered useful in the detection of malignant biliary strictures [81–83]. Multiple studies have demonstrated that FISH can increase the sensitivity of cytology brushing while preserving specificity [81,83–86]. The most recent study is that by Liew et al. [87], who performed a retrospective analysis of 30 consecutive patients who underwent both routine cytology and FISH performed at a tertiary care center. When used independently, routine brush cytology had a higher sensitivity (53.8% vs. 30.8%) but a lower specificity (82.4% vs. 100%) than FISH. However, when the FISH results were interpreted in cases of negative or atypical cytology findings, the sensitivity of brush cytology improved from 53.8% to 69.2% without compromising specificity.
A well-studied aspect of FISH is the detection of cholangiocarcinoma in PSC. PSC can be difficult to distinguish from cholangiocarcinoma because these two conditions can have similar imaging features [88]. In addition, some patients with PSC may progress to develop cholangiocarcinoma [89]. In such cases, FISH can be used to determine whether cholangiocarcinoma progression has occurred. A meta-analysis of eight studies involving 828 patients demonstrated that the pooled sensitivity and specificity for the diagnosis of cholangiocarcinoma in PSC were 68% (95% CI, 61–74%) and 70% (95% CI, 66–73%), respectively [90]. These results showed that FISH increases the sensitivity of tissue sampling only slightly in PSC. However, the high cost of FISH has prompted some endoscopists to be selective in using this tool for detecting malignancies [91]. FISH is not recommended as a screening tool for all patients with PSC but should be considered if the suspicion of malignancy remains high after an inconclusive brush cytology.
Optical coherence tomography
Optical coherence tomography (OCT) enables high-resolution cross-sectional imaging of the biliary tract [92]. The principle of OCT is similar to that of B-mode ultrasound, except that it uses infrared light instead of high-frequency sound. By measuring the intensity and time delay of backscattered infrared light, cross-sectional images of the biliary tract can be obtained in real time [93]. Neoplastic and normal tissues display different light-backscattering patterns, permitting OCT to differentiate between benign and malignant strictures [94]. The spatial resolution of OCT is almost equivalent to that of histology, allowing clear visualization of the epithelium, fibroconnective submucosa, and acinar tissue as a series of hyperreflective and hyporeflective layers [93,95]. Following ex vivo studies demonstrating that OCT could produce images of the bile duct to a depth of 1 mm, multiple subsequent in vivo studies showed characteristic changes that occur in benign and malignant strictures [96–98]. Arvanitakis et al. [99] evaluated the use of OCT in 37 patients with biliary strictures, and demonstrated that the sensitivity and specificity in detecting malignancy can reach 79% and 100%, respectively, depending on the criteria used.
Most of the studies on OCT have been based on first-generation devices that are no longer in production. The second-generation OCT system offers higher imaging speed without compromising image quality or spatial resolution [100]. Images retrieved using the newer-generation OCT system were still able to outline characteristic features of benign and malignant strictures, as evaluated by Tyberg et al. [101]. Both the first- and second-generation OCT devices were miniaturized enough that they could be inserted into the working channel of an endoscope [102]. Once positioned in the stricture, imaging of the stricture takes approximately 90 s and in vivo interpretation can be accomplished [101]. The relative efficiency of this technique in detecting features suggestive of malignancy has increased its approval among endoscopists. However, further studies with large numbers of prospective patients are needed to determine how OCT can be employed in future diagnostic algorithms for the evaluation of biliary strictures.
CONCLUSIONS
The evaluation of biliary strictures remains challenging despite recent advances in endoscopic techniques. The decision to favor one endoscopic approach over another should be individualized; however, the lack of large-scale prospective studies on newer modalities makes this decision difficult. The diagnosis of biliary strictures can be aided by developments in cytopathologic staining and imaging practices. Thus, a multidisciplinary approach involving endoscopists, surgeons, pathologists, and radiologists is necessary to provide a holistic direction for diagnosis. Future advances in endoscopy will undoubtedly improve the detection of malignant biliary strictures. In the meantime, clinicians should tailor their decision making to the clinical condition of individual patients when diagnosing biliary strictures.
Notes
Conflicts of Interest: The authors have no potential conflicts of interest.
Funding
None.
Author Contributions
Conceptualization: Roy Huynh, Corinne Owers, Christopher Pinto, Thuy-My Nguyen, Titus Kwok
Data curation: RH, CO, CP, TMN, TK
Formal analysis: RH
Funding acquisition
Investigation: RH
Methodology: RH
Project administration: RH, CO, CP, TMN, TK
Resources: CO, CP, TMN, TK
Software: RH, CO, CP, TMN, TK
Supervision: TK
Validation: RH, CO, CP, TMN, TK
Visualization: RH, CO, CP, TMN, TK
Writing-original draft: RH
Writing-review&editing: RH, CO, CP, TMN, TK